改善血液透析患者血比容積偏低專案

A Project to Improve Hemodialysis Patients' Low Hematocrit

黃文鳳(Wen-Feng Huang) ； 林品昀(Pin-Jun Lin) ； 鄭金鳳(Jin-Feng Zheng)

《領導護理》 10卷1期 (2009/04) Pp. 106-117

https://doi.org/10.29494/LN.200904.0011

摘要

An investigation showed that the average hematocrit (HCT) of the dialysis patients in this hospital was 28.7%, and 46% of the patients actually had a HCT lower than 28%. The average dosage of r-HuEPO administered per hemodialysis patient per month was as high as 19000U. The aim of a designed improvement project was to decrease the percentage rate of hemodialysis patients with low HCT (HCT ＜ 28%). The identified problems based on data analysis included insufficient iron supplement for patients receiving hemodialysis, patients' lack of knowledge about anemia, patients' poor nutritional status, incomplete blood transfusion return from the dialysis catheters, and patient's' poor absorption of r-HuEPO via intravenous route. The designed improvementmeasures changed the injection route for r-HuEPO administration, changed the brand of iron supplement to eliminate allergy, provided educational seminars on anemia, produced educational posters and DVD's, and established the procedure standards for the closure of hemodialysis. Since the above measures were implemented, the percentage of patients with low HCT had been reduced from 46% to 21%. The average dosage of r-HuEPO administered for hemodialysis patients had been reduced from 19000U to 15712U per patient per month. The project not only improved patients' anemic status, but also reduced the medical costs.

關鍵字

血液透析 ； 血比容偏低

並列摘要

An investigation showed that the average hematocrit (HCT) of the dialysis patients in this hospital was 28.7%, and 46% of the patients actually had a HCT lower than 28%. The average dosage of r-HuEPO administered per hemodialysis patient per month was as high as 19000U. The aim of a designed improvement project was to decrease the percentage rate of hemodialysis patients with low HCT (HCT ＜ 28%). The identified problems based on data analysis included insufficient iron supplement for patients receiving hemodialysis, patients' lack of knowledge about anemia, patients' poor nutritional status, incomplete blood transfusion return from the dialysis catheters, and patient's' poor absorption of r-HuEPO via intravenous route. The designed improvementmeasures changed the injection route for r-HuEPO administration, changed the brand of iron supplement to eliminate allergy, provided educational seminars on anemia, produced educational posters and DVD's, and established the procedure standards for the closure of hemodialysis. Since the above measures were implemented, the percentage of patients with low HCT had been reduced from 46% to 21%. The average dosage of r-HuEPO administered for hemodialysis patients had been reduced from 19000U to 15712U per patient per month. The project not only improved patients' anemic status, but also reduced the medical costs.

並列關鍵字

hemodialysis ； low hematocrit